143 related articles for article (PubMed ID: 24455220)
1. Successful Integration of Hepatitis C Virus Point-of-Care Tests into the Denver Metro Health Clinic.
Jewett A; Al-Tayyib AA; Ginnett L; Smith BD
AIDS Res Treat; 2013; 2013():528904. PubMed ID: 24455220
[TBL] [Abstract][Full Text] [Related]
2. Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNA.
Smookler D; Vanderhoff A; Biondi MJ; Valencia J; Ryan P; Karkada J; Hong R; Sattar I; Mandel E; Gjevori M; Casey J; Fletcher D; Shah H; Hansen BE; Capraru C; Janssen HLA; Lazarus JV; Feld JJ
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1451-1458.e4. PubMed ID: 32763480
[TBL] [Abstract][Full Text] [Related]
3. Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-care and standard HCV testing in a mobile medical clinic.
Morano JP; Zelenev A; Lombard A; Marcus R; Gibson BA; Altice FL
J Community Health; 2014 Oct; 39(5):922-34. PubMed ID: 25135842
[TBL] [Abstract][Full Text] [Related]
4. Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado.
Subiadur J; Harris JL; Rietmeijer CA
Public Health Rep; 2007; 122 Suppl 2(Suppl 2):12-7. PubMed ID: 17542447
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project.
Gunn RA; Murray PJ; Brennan CH; Callahan DB; Alter MJ; Margolis HS
Sex Transm Dis; 2003 Apr; 30(4):340-4. PubMed ID: 12671556
[TBL] [Abstract][Full Text] [Related]
6. Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia.
Uusküla A; Talu A; Rannap J; Barnes DM; Jarlais DD
Harm Reduct J; 2021 Apr; 18(1):39. PubMed ID: 33794927
[TBL] [Abstract][Full Text] [Related]
7. Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.
Masson CL; Fokuo JK; Anderson A; Powell J; Zevin B; Bush D; Khalili M
BMC Infect Dis; 2020 May; 20(1):386. PubMed ID: 32471376
[TBL] [Abstract][Full Text] [Related]
8. Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study.
Williams B; Howell J; Doyle J; Thompson AJ; Draper B; Layton C; Latham N; Bramwell F; Membrey D; Mcpherson M; Roney J; Stoové M; Hellard ME; Pedrana A
Int J Drug Policy; 2019 Oct; 72():91-98. PubMed ID: 31129023
[TBL] [Abstract][Full Text] [Related]
9. Point-of-care rapid testing for hepatitis C antibodies at New Zealand needle exchanges.
Noller G; Bourke J
N Z Med J; 2020 Nov; 133(1525):84-95. PubMed ID: 33223551
[TBL] [Abstract][Full Text] [Related]
10. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
11. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.
Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A
Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752
[TBL] [Abstract][Full Text] [Related]
12. Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance.
Pallarés C; Carvalho-Gomes Â; Hontangas V; Conde I; Di Maira T; Aguilera V; Benlloch S; Berenguer M; López-Labrador FX
J Clin Virol; 2018 May; 102():77-83. PubMed ID: 29525634
[TBL] [Abstract][Full Text] [Related]
13. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project.
Dong BJ; Lopez M; Cocohoba J
J Am Pharm Assoc (2003); 2017; 57(4):510-515.e2. PubMed ID: 28602784
[TBL] [Abstract][Full Text] [Related]
14. Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis.
Trickey A; Fajardo E; Alemu D; Artenie AA; Easterbrook P
Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):253-270. PubMed ID: 36706775
[TBL] [Abstract][Full Text] [Related]
15. Identifying barriers and facilitators along the hepatitis C care cascade to inform human-centered design of contextualized treatment protocols for vulnerable populations in Austin, Texas: a qualitative study.
Desai A; O'Neal L; Reinis K; Brown C; Stefanowicz M; Kuang A; Agrawal D; Bhavnani D; Mercer T
Implement Sci Commun; 2023 Aug; 4(1):98. PubMed ID: 37592306
[TBL] [Abstract][Full Text] [Related]
16. Point-of-care hepatitis C screening with direct access referral to improve linkage to care among halfway house residents: a pilot randomised study.
Hsiang JC; Sinnaswami P; Lee MY; Zhang MM; Quek KE; Tan KH; Wong YM; Thurairajah PH
Singapore Med J; 2022 Feb; 63(2):86-92. PubMed ID: 32729280
[TBL] [Abstract][Full Text] [Related]
17. Integrating Routine HCV Testing in Primary Care: Lessons Learned from Five Federally Qualified Health Centers in Philadelphia, Pennsylvania, 2012-2014.
Coyle C; Kwakwa H; Viner K
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):65-73. PubMed ID: 27168664
[TBL] [Abstract][Full Text] [Related]
18. Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison.
Byrne CJ; Malaguti A; Inglis SK; Dillon JF
BMJ Open; 2023 Apr; 13(4):e068604. PubMed ID: 37037621
[TBL] [Abstract][Full Text] [Related]
19. Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective, observational cohort study.
Lettner B; Mason K; Greenwald ZR; Broad J; Mandel E; Feld JJ; Powis J
Lancet Reg Health Am; 2023 Jun; 22():100490. PubMed ID: 37388709
[TBL] [Abstract][Full Text] [Related]
20. HCV and HIV counseling and testing integration in California: an innovative approach to increase HIV counseling and testing rates.
Stopka TJ; Marshall C; Bluthenthal RN; Webb DS; Truax SR
Public Health Rep; 2007; 122 Suppl 2(Suppl 2):68-73. PubMed ID: 17542457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
